Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis. Archivio Italiano di Urologia e Andrologia, [S. l.], v. 87, n. 2, p. 121–129, 2015. DOI: 10.4081/aiua.2015.2.121. Disponível em: https://www.pagepressjournals.org/aiua/article/view/aiua.2015.2.121. Acesso em: 22 may. 2026.